Gunter Krause
Joseph Stelzmann Str. 26
Koeln, NW 50931, Germany
Koeln, NW 50931, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ.
Journal: Communications biology
Published: August 21, 2022
Relevant Cytokines in the B Cell Lymphoma Micro-Environment.
Journal: Cancers
Published: July 03, 2020
Cell line-based assessment of BTK inhibitors.
Journal: British journal of pharmacology
Published: October 18, 2019
Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib.
Journal: Drug design, development and therapy
Published: September 04, 2018
Sensitive Detection of the Natural Killer Cell-Mediated Cytotoxicity of Anti-CD20 Antibodies and Its Impairment by B-Cell Receptor Pathway Inhibitors.
Journal: BioMed research international
Published: October 26, 2017
Establishing a chemical genetic link between Bruton tyrosine kinase activity in malignant B cells and cell functions involved in the micro-environmental dialogue.
Journal: British journal of haematology
Published: February 06, 2017
Cytotoxicity of the CD37 antibody BI 836826 against chronic lymphocytic leukaemia cells in combination with chemotherapeutic agents or PI3K inhibitors.
Journal: British journal of haematology
Published: August 15, 2015
Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells.
Journal: International journal of cancer
Published: November 30, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026